vigabatrin

FDA Drug Profile — vigabatrin for oral solution, vigabatrin, VIGAFYDE, VIGABATRIN, SABRIL

vigabatrin is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including vigabatrin for oral solution, vigabatrin, VIGAFYDE. Available dosage forms: powder, for solution, tablet, film coated, solution, for solution.

Drug details

Generic Name
vigabatrin
Brand Names
vigabatrin for oral solution, vigabatrin, VIGAFYDE, VIGABATRIN, SABRIL, VIGADRONE, Vigabatrin
Application Number
ANDA213519
Sponsor
Camber Pharmaceuticals, Inc.
NDC Codes
15
Dosage Forms
POWDER, FOR SOLUTION, TABLET, FILM COATED, SOLUTION, FOR SOLUTION
Routes
ORAL
Active Ingredients
VIGABATRIN

Indications and Usage

1 INDICATIONS AND USAGE Vigabatrin tablets are indicated for the treatment of: • Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; Vigabatrin tablets are not indicated as a first line agent ( 1.1 ) • Infantile Spasms - monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1.2 ) 1.1 Refractory Complex Partial Seizures (CPS) Vigabatrin tablets are indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss [see Warnings and Precautions ( 5.1 ) ]. Vigabatrin tablets are not indicated as a first line agent for complex partial seizures. 1.2 Infantile Spasms (IS) Vigabatrin tablets are indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [ see Warnings and Precautions ( 5.1 ) ]

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.